Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif
| dc.authorid | 0000-0003-3667-6902 | |
| dc.contributor.author | Demir, Yeliz | |
| dc.contributor.author | Türkeş, Cüneyt | |
| dc.contributor.author | Çavuş, Muhammet Serdar | |
| dc.contributor.author | Erdoğan, Musa | |
| dc.contributor.author | Muğlu, Halit | |
| dc.contributor.author | Yakan, Hasan | |
| dc.contributor.author | Beydemir, Şükrü | |
| dc.date.accessioned | 2023-05-25T13:35:14Z | |
| dc.date.available | 2023-05-25T13:35:14Z | |
| dc.date.issued | 2023 | en_US |
| dc.department | Rektörlük, Rektör | |
| dc.description.abstract | New Schiff base‐bearing thiosemicarbazones (1–13) were obtained from 4‐hydroxy‐3, 5‐dimethoxy benzaldehyde and various isocyanates. The structures of the synthesized molecules were elucidated in detail. Density functional theory calculations were also performed to determine the spectroscopic properties of the compounds. Moreover, the enzyme inhibition activities of these compounds were investigated. They showed highly potent inhibition effects on acetylcholinesterase (AChE) and human carbonic anhydrases (hCAs) (KI values are in the range of 51.11 ± 6.01 to 278.10 ± 40.55 nM, 60.32 ± 9.78 to 300.00 ± 77.41 nM, and 64.21 ± 9.99 to 307.70 ± 61.35 nM for AChE, hCA I, and hCA II, respectively). In addition, molecular docking studies were performed, confirmed by binding affinities studies of the most potent derivatives. | en_US |
| dc.description.pubmedpublicationid | PMID: 36575148 | en_US |
| dc.description.sponsorship | Bu yayın "Anadolu University, 2102S003" tarafından desteklenmiştir. | en_US |
| dc.identifier.citation | Demir Y, Türkeş C, Çavuş MS, Erdoğan M, Muğlu H, Yakan H, Beydemir Ş. Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif. Arch Pharm (Weinheim). 2023 Apr;356(4):e2200554. doi: 10.1002/ardp.202200554. Epub 2022 Dec 27. PMID: 36575148. | en_US |
| dc.identifier.doi | 10.1002/ardp.202200554 | |
| dc.identifier.issn | 0365-6233 | |
| dc.identifier.issn | 1521-4184 | |
| dc.identifier.issue | 4 | en_US |
| dc.identifier.pmid | 36575148 | |
| dc.identifier.scopus | 2-s2.0-85145266945 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://doi.org/10.1002/ardp.202200554 | |
| dc.identifier.uri | https://hdl.handle.net/11552/2989 | |
| dc.identifier.volume | 356 | en_US |
| dc.identifier.wos | WOS:000903773400001 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | PubMed | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | WoS | |
| dc.indekslendigikaynak | WoS - Science Citation Index Expanded | |
| dc.institutionauthor | Beydemir, Şükrü | |
| dc.language.iso | en | |
| dc.publisher | Wiley | en_US |
| dc.relation.ispartof | Archiv der Pharmazie | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | DFT | en_US |
| dc.subject | Enzyme Inhibition | en_US |
| dc.subject | Molecular Docking | en_US |
| dc.subject | Spectroscopic Elucidation | en_US |
| dc.subject | Thiosemicarbazones | en_US |
| dc.title | Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- Archiv der Pharmazie - 2022 - Demir - Enzyme inhibition molecular docking and density functional theory studies of new.pdf
- Boyut:
- 4.85 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Yayıncı Kopyası_Makale Dosyası
Lisans paketi
1 - 1 / 1
Yükleniyor...
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama:












